Deferasirox (Exjade®, ICL670) Is Effective and Tolerable in β-Thalassemia Patients with High Iron Burden and History of Inadequate Chelation Therapy
Taher, A., El-Beshlawy, A., Al Jefri, A., Elalfy, M., Al Zir, K., Daar, S., Damanhouri, G., Krahn, U., Hadler, D.
Published in Blood (16.11.2006)
Published in Blood (16.11.2006)
Get full text
Journal Article